Novosanis celebrates 2nd anniversary!

Novosanis is a medical device company and spin-off from the University of Antwerp, Belgium. We currently have two device platforms in our portfolio: VAX-ID, suited for accurate injection of e.g. vaccines and biologicals in the dermal layer of the skin and Colli-Pee, suited for collection of standardized first void urine allowing for detection of infectious diseases as well as cancer biomarkers.  

“We are very proud of the progress Novosanis has made over the last two years and our achievements. We have successfully applied for funding at IWT, which allows for more profound and in-depth research & development for both VAX-ID as well as Colli-Pee. We have obtained several design awards for both our devices and as icing on the cake, the Colli-Pee obtained CE-IVD last December. Also, over the last two years our company has grown to a wonderful and motivated team of five seasoned experts in (bio) medical sciences, product development and engineering.” says Vanessa Vankerckhoven, CEO.

Belgian James Dyson Award for VAX-ID

Koen Beyers, Chief Technology Officer at Novosanis, “it was a pleasure to inspire Ruben Camerlynck as a student and joining forces with a multidisciplinary team to generate a state-of-the-art device. It has been an exciting process and we are extremely pleased with the products’ unique architecture, smart mechanisms, and use of materials.’’

Successful funding applications at IWT 

Koen Beyers, Chief Technology Officer, "This IWT grant will provide an additional boost to our development and development of the VAX-ID devices. The research will now be more profound and elaborate as more parameters can be implemented. Also, we will be able to engage faster with pharmaceutical and vaccine companies. "

Colli-Pee CE labelled, awarded at design week and nominated for IWT Innovation Award

Timothi Van Mulder, Quality Manager: ‘Novosanis NV strives to develop and manufacture highly qualitative devices for healthcare applications. The first years of development and research have led to obtaining the CE label for the Colli-Pee device. Launching Colli-Pee on the market is an excellent reward for the hard work of the entire team.’

Together we will continue developing and commercializing our medical devices, as it is the heart of our company!